Showing results (1791-1800 of 2,394) with videos related to
Sort By:
Pageof 240
The AAPS Journal|September 10, 2026
Verification of a Physiologically-based Pharmacokinetic Model for Predicting CYP3A4-mediated Simvastatin and Simvastatin Acid Drug-drug InteractionsBridget L Morse, Bing Han, Jeffrey J Alberts, et al.The AAPS Journal|September 18, 2026
Investigating the Role of Phenolic Acid Coformers in Enhancing the Physicochemical Properties of Enzalutamide Coamorphous SystemsVenkata Krishna Rao Balaga, Argyro Chatziadi, Luděk Ridvan, et al.The AAPS Journal|September 22, 2026
Immunogenicity Profile of Lonapegsomatropin During Long-Term Treatment in Children With Growth Hormone DeficiencyPer Holse Mygind, Amiee Weiser, Camilla Melin Fürst, et al.The AAPS Journal|September 9, 2026
Decoding Nonlinearities in AAV-Based Gene Therapy Using PBPK ModellingAneesh Rajwade, Shufang Liu, Mokshada Kumar, et al.The AAPS Journal|September 12, 2026
Engineering and Characterisation of 3D-Printed Timolol Maleate Implants for Long-Acting Glaucoma TreatmentFebri Annuryanti, Masoud Adhami, Eneko Larrañeta, et al.The AAPS Journal|September 12, 2026
Four decades of History & Evolution of Clinical Pharmacology at US Food and Drug Administration (FDA)- Part I: Product QualityMehul MehtaThe AAPS Journal|September 12, 2026
Commentary on "Reference Standard Calibration Challenges in the Case of Erythropoietin: Impact on Potency and Biosimilarity Determination"Ben Cowper, Peter Rigsby, Chris BurnsThe AAPS Journal|September 28, 2026
Population Pharmacokinetics and Exposure-response Analysis of Durvalumab in Patients with Limited-stage Small-cell Lung Cancer in the Phase 3 ADRIATIC StudyHong Su, Becky Jiajia Zhao, Yu Fu, et al.The AAPS Journal|October 5, 2026
Utilization of Brain Physiologically Based Pharmacokinetic Modeling in Support of CNS Drug Development: Case Example of FenebrutinibChristine M Bowman, Fang Ma, Yan Xu, et al.The AAPS Journal|April 6, 2022
A Model-Based Approach to Bridging Plasma and Dried Blood Spot Concentration Data for Phase 3 Verubecestat TrialsMarissa F Dockendorf, David Jaworowicz, Rebecca Humphrey, et al.Pageof 240